Eisen, A., Greenberg, B. M., Bowen, J. D., Arnold, D. L., & Caggiano, A. O. (2017). A double-blind, placebo-controlled, single ascending-dose study of remyelinating antibody rHIgM22 in people with multiple sclerosis. Mult Scler J Exp Transl Clin.

Eisen, Andrew, Benjamin M. Greenberg, James D. Bowen, Douglas L. Arnold, and Anthony O. Caggiano. "A Double-blind, Placebo-controlled, Single Ascending-dose Study of Remyelinating Antibody RHIgM22 in People With Multiple Sclerosis." Mult Scler J Exp Transl Clin 2017.

Eisen, Andrew, et al. "A Double-blind, Placebo-controlled, Single Ascending-dose Study of Remyelinating Antibody RHIgM22 in People With Multiple Sclerosis." Mult Scler J Exp Transl Clin 2017.